Intensive care unit admission in multiple sclerosis: Increased incidence and increased mortality

Neurology

Volumn 82, Issue 23, 2014, Pages 2112-2119

  Marrie, Ruth Ann ^a   Bernstein, Charles N ^a   Peschken, Christine A ^a   Hitchon, Carol A ^a   Chen, Hui ^b   Fransoo, Randy ^a,b   Garland, Allan ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANADA; CAUSE OF DEATH; COMORBIDITY; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE DURATION; FEMALE; GROUPS BY AGE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; INFECTION; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RISK FACTOR; RURAL AREA; SOCIAL STATUS; URBAN AREA;

ADULT; AGE FACTORS; AGED; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; INFECTION; INTENSIVE CARE UNITS; MALE; MANITOBA; MIDDLE AGED; MULTIPLE SCLEROSIS; PATIENT ADMISSION; PREVALENCE; RISK; TIME FACTORS;

EID: 84903976127     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000495     Document Type: Article

References (29)

1. Jacobs P, Noseworthy TW. National estimates of intensive care utilization and costs: Canada and the United States. Crit Care Med 1990;18: 1282-1286.
2. Sirio CA, Tajimi K, Taenaka N, Ujike Y, Okamoto K, Katsuya H. A cross-cultural comparison of critical care delivery: Japan and the United States. Chest 2002;121: 539-548.
3. Wunsch H, Angus DC, Harrison DA, et al. Variation in critical care services across North America and Western Europe. Crit Care Med 2008;36: 2787-2793.
4. Halpern NA, Bettes L, Greenstein R. Federal and nationwide intensive care units and healthcare costs: 1986-1992. Crit Care Med 1994;22: 2001-2007.
5. Williams TA, Dobb GJ, Finn JC, et al. Determinants of long-Term survival after intensive care. Crit Care Med 2008; 36: 1523-1530.
6. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system. Chest 1991;100: 1619-1636.
7. RedelingsMD,McCoy L, Sorvillo F.Multiple sclerosis mortality and patterns of comorbidity in the United States from 1990 to 2001. Neuroepidemiology 2006;26: 102-107.
8. Jadidi E, Mohammadi M, Moradi T. High risk of cardiovascular diseases after diagnosis of multiple sclerosis. Mult Scler J 2013;19: 1336-1340.
9. Marrie RA, Yu BN, Leung S, et al. Prevalence and incidence of ischemic heart disease in multiple sclerosis: a population-based validation study. Mult Scler Relat Disord 2013;2: 355-361.
10. Fleming ST. Multiple sclerosis as a comorbidity: a study of resource utilization and outcomes of care. Clin Perform Qual Health Care 1995;3: 23-30.
11. Pittock SJ, Weinshenker BG, Wijdicks EFM. Mechanical ventilation and tracheostomy in multiple sclerosis. J Neurol Neurosurg Psychiatry 2004;75: 1331-1333.
12. Fried TR, Bradley EH. What matters to seriously ill older persons making end-of-life treatment decisions? A qualitative study. J Palliat Med 2003;6: 237-244.
13. Fried TR, Bradley EH, Owle VT, Allore H. Understanding the treatment preferences of seriously ill patients. N Engl J Med 2002;346: 1061-1066.
14. Stevenson LW, Hellkamp AS, Leier CV, et al. Changing preferences for survival after hospitalization with advanced heart failure. J Am Coll Cardiol 2008;52: 1702-1708.
15. Murphy DJ, Burrows D, Santilli S, et al. The influence of the probability of survival on patients' preferences regarding cardiopulmonary resuscitation. N Engl J Med 1994;330: 545-549.
16. Health Information Management Branch. Population Report. Winnipeg: Manitoba Health and Healthy Living; 2008.
17. Garland A, Yogendran M, Olafson K, Scales DC, McGowan KL, Fransoo R. The accuracy of administrative data for identifying the presence and timing of admission to intensive care units in a Canadian province. Med Care 2012;50: e1-e6.
18. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. Lancet 1974;2: 81-84.
19. Marrie RA, Yu N, Blanchard JF, Leung S, Elliott L. The rising prevalence and changing age distribution of multiple sclerosis in Manitoba. Neurology 2010;74: 465-471.
20. Haupt MT, Bekes CE, Brilli RJ, et al. Guidelines on critical care services and personnel: recommendations based on a system of categorization of three levels of care. Crit Care Med 2003;31: 2677-2683.
21. Needham DM, Scales DC, Laupacis A, Pronovost PJ. A systematic review of the Charlson Comorbidity Index using Canadian administrative databases: a perspective on risk adjustment in critical care research. J Crit Care 2005;20: 12-19.
22. Garland A, Fransoo R, Olafson K, et al. The Epidemiology and Outcomes of Critical Illness in Manitoba. Winnipeg: Manitoba Centre for Health Policy; 2012.
23. Preen DB, Holman CDAJ, Spilsbury K, Semmens JB, Brameld KJ. Length of comorbidity lookback period affected regression model performance of administrative health data. J Clin Epidemiol 2006;59: 940-946.
24. Camargo JF, Tobon GJ, Fonseca N, et al. Autoimmune rheumatic diseases in the intensive care unit: experience from a tertiary referral hospital and review of the literature. Lupus 2005;14: 315-320.
25. Kleinbaum D, Klein M. Logistic Regression: A Self-Learning Text, 2nd ed. New York: Springer-Verlag; 2002.
26. Statistics Canada. Vital Statistics: Death Database [online]. Available at: http://www.statcan.gc.ca/cgi-bin/imdb/p2SV.pl? Function5getSurvey& SDDS53233&lang5en&db5imdb &adm58&dis52. Accessed March 6, 2011.
27. McCrone P, Heslin M, Knapp M, Bull P, Thompson A. Multiple sclerosis in the UK: service use, costs, quality of life and disability. Pharmacoeconomics 2008;26: 847-860.
28. Broemeling A, Watson DE, Prebtani F; Councillors of the Health Outcomes Steering Committee of the Health Council of Canada. Population patterns of chronic health conditions, co-morbidity and health care use in Canada: implications for policy and practice. Healthc Q 2008;11: 70-76.
29. Menon S, Shirani A, Zhao Y, et al. Characterising aggressive multiple sclerosis. J Neurol Neurosurg Psychiatry 2013;84: 1192-1198.